Á. Montero

ORCID: 0000-0001-5566-0493
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Advanced Radiotherapy Techniques
  • Breast Cancer Treatment Studies
  • Sarcoma Diagnosis and Treatment
  • Breast Lesions and Carcinomas
  • Vascular Tumors and Angiosarcomas
  • Effects of Radiation Exposure
  • Prostate Cancer Treatment and Research
  • Advances in Oncology and Radiotherapy
  • Management of metastatic bone disease
  • Prostate Cancer Diagnosis and Treatment
  • Breast Implant and Reconstruction
  • Lung Cancer Diagnosis and Treatment
  • COVID-19 and healthcare impacts
  • Ultrasound and Hyperthermia Applications
  • Bone Tumor Diagnosis and Treatments
  • Head and Neck Cancer Studies
  • Medical Imaging Techniques and Applications
  • Cardiac tumors and thrombi
  • Cancer Cells and Metastasis
  • Brain Metastases and Treatment
  • Nonmelanoma Skin Cancer Studies
  • Global Cancer Incidence and Screening
  • Radiation Dose and Imaging
  • Spine and Intervertebral Disc Pathology
  • Cutaneous Melanoma Detection and Management

HM Hospitales
2017-2025

Camilo José Cela University
2023-2025

Hospital Universitario HM Sanchinarro
2015-2024

Sociedad Española de Cardiología
2017

Sociedad Española de Oncología Médica
2017

Memorial Sloan Kettering Cancer Center
2017

The Barbara Ann Karmanos Cancer Institute
2017

Indiana University School of Medicine
2017

MedStar Georgetown University Hospital
2017

Georgetown University
2017

✓ The influence of the type intracranial lesion on final outcome in a consecutive series 277 severely head-injured patients was analyzed. Patients were studied with computerized tomograpy (CT) and underwent continuous measurement pressure. They received identical treatment according to standardized protocol. Outcome either epidural hematoma (38 cases), subdural (56 brain contusion (87 or diffuse damage (96 cases) rather heterogeneous, serial CT scanning allowed authors outline eight...

10.3171/jns.1983.59.5.0762 article EN Journal of neurosurgery 1983-11-01

F<sub>2</sub>-isoprostanes mediate high glucose-induced TGF-β synthesis and glomerular proteinuria in experimental type I diabetes. <h3>Background</h3> The recently discovered arachidonic acid derivatives, isoprostanes, are increased pathological conditions associated with oxidative stress, such as No role has yet been described for isoprostanes during the development of diabetic nephropathy. Cell culture ambient glucose used a model elucidating cellular mechanisms underlying Among growth...

10.1111/j.1523-1755.2000.00368.x article EN cc-by-nc-nd Kidney International 2000-11-01

Act.In.Sarc (NCT02379845) demonstrated that the first-in-class radioenhancer NBTXR3, activated by preoperative radiation therapy (RT), doubled rate of pathologic complete response after resection compared with RT alone in adult patients locally advanced soft tissue sarcoma extremity or trunk wall (16.1% vs 7.9%, P = .045), and more achieved R0 resections (77.0% 64.0%, .042). These are toxicity health-related quality life (HRQoL) results.Act.In.Sarc randomized eligible 1:1 to either NBTXR3...

10.1016/j.ijrobp.2022.07.001 article EN cc-by International Journal of Radiation Oncology*Biology*Physics 2022-07-16

PurposeModerate hypofractionated radiotherapy is the standard of care for all patients with breast cancer, irrespective stage or prior treatments. While extreme hypofractionation accepted early-stage tumours, its application in irradiating locoregional lymph nodes remains controversial.Materials and methodsA prospective registry analysis from July 2020 to September 2023 included 276 cancer treated one-week ultra-hypofractionation (UHF) at 26 Gy 5 fractions on whole (58.3 %) thoracic wall...

10.1016/j.ctro.2024.100764 article EN cc-by-nc-nd Clinical and Translational Radiation Oncology 2024-03-13

Whole-breast irradiation (WBI) after breast conserving surgery (BCS) is indicated to improve loco-regional control and survival. Former studies showed that addition of tumor bed boost in all age groups significantly improved local although no apparent impact on overall survival but with an increased risk worse cosmetic outcome. Even though shortened regimens 3 weeks are considered the standard, recent have shown non-inferiority a treatment regimen 5 fractions one-week both locoregional...

10.1016/j.ctro.2023.100651 article EN cc-by-nc-nd Clinical and Translational Radiation Oncology 2023-06-15
Coming Soon ...